Trial Profile
Clinical trial of a change-over from Torasemide to Tolvaptan for chronic heart failure after cardiac surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Chronic heart failure
- Focus Biomarker; Therapeutic Use
- 03 Jan 2013 New trial record